Concepedia

Mark S. Sulkowski

MS

Statistics

Publications

12

Citations

1.4K

H-Index

12

Active since

2004

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

Beth Israel Deaconess Medical Center

Duke University

Cornell University

Mark S. Sulkowski is an author at Johns Hopkins Medicine specializing in viral hepatitis, antiviral therapy, and infectious diseases.

Publications per year

2004–2025

12

Publications

12

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Alexander Thompson, Andrew J. Muir, Mark S. Sulkowski et al. · Gastroenterology · 2010 · 723 citations · Full text

, , +17

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

Mark S. Sulkowski, Shruti H. Mehta, Michael Torbenson et al. · AIDS · 2005 · 175 citations

, , +16

Epoetin Alfa Improves Quality of Life in Anemic Hcv–Infected Patients Receiving Combination Therapy

Paul J. Pockros, Mitchell L. Shiffman, Eugene R. Schiff et al. · Hepatology · 2004 · 145 citations · Full text

, , +14

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

Mark S. Sulkowski, Fred Poordad, M.P. Manns et al. · Hepatology · 2012 · 73 citations · Full text

, , +17

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki et al. · Hepatology · 2013 · 68 citations · Full text

, , +16

1–5 of 12